QABY Biotech

QABY Biotech is a biotechnology company based in Doha (Qatar) dedicated to transforming the diagnosis and treatment of neurodegenerative diseases through precision medicine. Our proprietary platform integrates two synergistic innovations: A portfolio of highly sensitive immunoassays for detecting disease-associated α-synuclein aggregates, and therapeutic nanobodies designed to neutralize the toxic forms of the protein. This dual strategy positions QABY as a precision medicine company with near-term revenue potential from diagnostics and long-term high-value growth from its therapeutic pipeline.